Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIVV

Bioverativ (BIVV) Stock Price, News & Analysis

Bioverativ logo

About Bioverativ Stock (NASDAQ:BIVV)

Advanced Chart

Key Stats

Today's Range
$104.98
$104.98
50-Day Range
$104.98
$104.98
52-Week Range
$48.14
$105.01
Volume
N/A
Average Volume
3.03 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIVV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioverativ and its competitors with MarketBeat's FREE daily newsletter.

BIVV Stock News Headlines

Biogen Inc 0R1B Stock Quote
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
EDU Crosses Above Average Analyst Target
See More Headlines

BIVV Stock Analysis - Frequently Asked Questions

Bioverativ Inc. (NASDAQ:BIVV) announced its quarterly earnings data on Thursday, October, 26th. The biotechnology company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.55 by $0.25. The company's revenue was up 27.2% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioverativ investors own include Rexford Industrial Realty (REXR), Biogen (BIIB), Spark Therapeutics (ONCE), Bristol Myers Squibb (BMY), Phillips 66 (PSX), Gilead Sciences (GILD) and Marinus Pharmaceuticals (MRNS).

Company Calendar

Last Earnings
10/26/2017
Today
8/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:BIVV
CIK
1681689
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:BIVV) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners